In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit desired safety and dosage goals.
Dr Marc Laniado made a choice to be more mindful of his own health - here's what he discovered, from 'exercise snacking' to ...
Around 247 in every 100,000 people in the UK are thought to die from cancer in any given year, which is a 29% drop on the peak in 1989 (around 355 per 100,000). The data shows that ovarian cancer ...